SlideShare une entreprise Scribd logo
1  sur  45
Interstitial Lung Disease &
Pulmonary Infection
Dr. Vinita Singh
CASE-1
A routine chest X- ray performed on an asymptomatic
adult man who works at sandblasting reveals a fine
nodularity in the upper zone of the lung and “eggshell”
calcification of the hilar lymph nodes.
The Pt. S.calcium level is 9.8m/dl total protein is7.2g/dl.
He denies any H/O drug use or ciggarette smoking.
Cond,
A biopsy from lung reveal birefringent
particles within macrophages and fibrosis of
lung.
what is the material ?
CASE -2
A 65yr old man who just retired after having
worked for many years as a shipyard worker
presents with increasing shortness of breath.
Pertinent medical history is that he has been
a long time smoker.
A CT Scan of his chest reveals thick , pleural
Plaques on the surface of his lungs.
Cond,
The Dumbbell – Shaped structures were found
to stain blue with a prussian blue stain .
What are these structures ?
IMPORTANT CAUSES OF ILD
1. Primary or idiopathic
• Idiopathic Pulmonary Fibrosis
• Nonspecific interstitial pneumonia (NSIP)
• Organising pneumonia (OP)
• Respiratory bronchiolitis (RB)
• Diffuse alveolar damage (DAD)
• Desquamative interstitial pneumonia (DIP)
• Lymphocytic interstitial pneumonia (LIP)
Secondary Causes
1.Infectious
• Tuberculosis
• Bacterial
• Fungal
• Parasitic
• Viral
2. Noninfectious
• Hypersensitivity pneumonitis
• Pneumoconiosis
• Drug induced
• Radiation induced
• Malignancies
Association with diseases of unknown
aetiology
• Sarcoidosis
• Connective tissue disorders
• Systemic sclerosis
• Rheumatoid arthritis
• Dermatomyositis,Polymyositis
• SLE
• Chronic eosinophilic pneumonia
ILD is a heterogeneous syndrome with the following
common clinical features:
1. Exertional dyspnea
2. Bilateral diffuse infiltrates on chest radiographs
3. Physiological abnormalities with a restrictive lung defect,
decreased diffusing capacity (DLco) and abnormal alveolar-
arterial oxygen gradient (PAO2 – PaO2) at rest or with exertion.
4. Absence of pulmonary infection and neoplasm.
5. Histopathology with varing degrees of fibrosis and
inflammation with or without evidence of granulomatous or
secondary vascular changes in the pulmonary parenchyma.
Diffuse Parenchymal Lung Disease (DPLD)
DPLD of known cause, eg,
drugs or association, eg,
collagen vascular disease
Idiopathic
interstitial
pneumonias
Granulomatous
DPLD, eg,
sarcoidosis
Other forms of
DPLD, eg, LAM,
HX, etc
Idiopathic
pulmonary
fibrosis
IIP other than idiopathic
pulmonary fibrosis
Desquamative interstitial
pneumonia
Acute interstitial pneumonia
Nonspecific interstitial
pneumonia (provisional)
Respiratory bronchiolitis
interstitial lung disease
Cryptogenic organizing
pneumonia
Lymphocytic interstitial
pneumonia
ATS/ERS Consensus Statement. Am J Respir Crit Care Med. 2002;165:277-304.
PATHOLOGY
• Pulmonary interstitium is the anatomical space
between the alveolar and the capillary basement
membranes.
• Contains mesenchymal and connective tissue
cells and extra cellular matrix composed of
collagen, elastin and proteoglycans.
• Involvement of interstitium+ adjoining alveolar
epithelial+ Capillary endothelial cells.
• Disease encroaches alveolar spaces involving
acini, terminal bronchioles and overlying pleura.
Inhaled environmental agents
(fumes, dust, smoke)
Alveolar epithelial cell injury
Wound healing (inflammation,
coagulation, epithelial/endothelial
repair)
Pulmonary
fibrosis
Normal
Chronic airflow
obstruction
Genetic
predisposition
Delivery
&
persistence
Biochemical
Immunologic
Fibrotic
Four proposed mechanisms and potential variations in lung
responses to inhaled agents
Recent Hypothesis:
• Inflammatory hypothesis
• Epithelial Cell Apoptosis
• Angiogenesis
• Abnormal Matrix Turnover
• Th1 versus Th2 Cytokines
• Growth Factor Production
• Altered Fibroblast Phenotypes
• Myofibroblast Recruitment and Maintenance
Thannickal VJ, et al. Annu Rev Med. 2004;55:395-417.
AGE
GENETIC FACTORS
ENVIRONMENTAL FACTORS
NATURE OF INJURY
– Etiologic agent
– Recurrent vs single
– Endothelial vs epithelial
Histopathologic Pattern
DIP RB-ILD LIP COP NSIP AIP UIP
Inflammation
Fibrosis
LUNG INJURY
PATTERNS ON CHEST X-RAY
LINEAR
reticular
NODULAR
RETICULONODULAR
Normal Lung- cut surface and pleura smooth and homogenous
IPF- cut surface demonstrates patchy involvement of lung with fibrous scarring
around dilated airspaces forming a honey comb pattern
IPF
CASE-3
A 24yr old African American woman presents
with nonspecific symptoms including fever
malaise.
A chest X –ray reveals enlarged hilar lymph
nodes ( potato nodes) .
serum calcium level is found to be elevated
What is the probable diagnosis ?
CASE -4
A 61yr old man presents with increasing
shortness of breath .
A chest X- ray reveals diff. Pulmonary infiltrate.
transbronchial biopsy reveals fibrosis of the
walls of the alveoli, many of which contain
sheets of “ desquamated’’ cells.
What is the probable diagnosis ?
CASE -5
A 37yr old woman presents with acute onset
of a productive cough, fever, chills and pleuritic
chest pain.
A chest X –ray reveals consolidation of the
entire lower lobe of her right lung .
Histologic examination of lung tissue reveals
multiple suppurative , neutrophil – rich exudates
filing bronchi , bronchioles and alveolar spaces.
Cont’
1. What is the probable diagnosis?
2. What is the etio – pathogenesis ?
Etiology
• Decreased resistance - General/immune
• Virulent infection - Lobar pneumonia
• Defense Mechanisms
In the normal respiratory system there are a
number of important defense mechanisms that
protect the lung from infection. These include:
– Reflex closure of the vocal cords
– Cough reflex
– Mucociliary clearance
– Macrophage activity and immune competence.
• An increased risk of bacterial
infection is associated with impairment
of the defense mechanism, as in any of
these clinical situations:
– Loss of consciousness
– Immunodeficiency state
– Pulmonary edema
– Neutropenia
– Chronic airway obstruction
– Viral infection.
• Exudate
The exudate in bacterial pneumonia is
typically composed of varying proportions of:
– edema fluid
– red blood cells
– leukocytes (principally neutrophils)
– fibrin
• The cellular exudate in acute bacterial
pneumonia is in the alveolar spaces and distal
bronchioles though in severe cases the major
airways may also be filled with purulent
secretion.
Types
• Viral
• Bacterial
• Mycoplasmal
• Fungal
The Pneumonia Syndromes
• Community-acquired
acute pneumonia
– Streptococcus pneumonia
– Haemophilus influenza
– Moraxella catarrhalis
– Staphylococcus aureus
– Legionella pneumophilia
– Klebsiella
– Pseudomonas
• Community-acquired
atypical pneumonia
– Mycoplasma
– Chlamydia
– Legionella
– Viruses (RSV,
parainfluenza & influenza,
adenovirus)
• Nosocomial pneumonia
– Gram negative rods
– Staphlyococcus aureus
• Aspiration pneumonia
– Anaerobic oral flora
– Amniotic fluid
– Gastric content
– Chemicals
• Chronic pneumonia
– Nocardia
– Actinomyces
– Granulomatous
• Necrotizing pneumonia
– Anaerobic
– Staphlyococcus aureus
– Klebsiella
– Streptococcus pyogens
Several possible routes of infection of
the lung exist:
– Aspiration of contaminated secretions--
most common
– Inhalation of infected airborne droplets
– Bacteremia
– Direct extension of an acute inflammatory
process from an adjacent organ or
structure.
Routes of Infection
Etiopathogenesis
• Causes of bacterial pneumonia can be categorized as
extrinsic and intrinsic.
• Extrinsic factors : infection with respiratory
pathogens. Exposure to pulmonary irritants or direct
pulmonary injury causes noninfectious pneumonitis.
– Infectious agents responsible for bacterial
pneumonias include S. pneumoniae and H. influenzae;
Klebsiella, Staphylococcus, and Legionella species;
and gram-negative organisms.
– Aspiration and inhalation of aerosols containing the
bacterial pathogen are the most common modes of
infection.
– Some bacteria, such as Staphylococcus species, may
spread to the lungs hematogenously.
• S. pneumoniae is the most common cause of bacterial
pneumonia.
• Pneumonia from H influenzae often is associated with
debilitating conditions such as asthma, COPD, smoking,
and a compromised immune system.
• K. pneumoniae may cause a severe necrotizing lobar
pneumonia in patients with chronic alcoholism, diabetes,
or COPD.
• S. aureus pneumonia is observed in those who abuse
intravenous drugs.
– S. aureus generally occurs in hospitalized patients and
patients with prosthetic devices; it spreads
hematogenously to the lungs from contaminated local
sites. This pathogen also is an important cause of
pneumonia following infection with influenza A.
• L. pneumophila infections occur either sporadically or as
local outbreaks.
• Gram-negative pneumonias are
observed in individuals who are
immunocompromised or
hospitalized.
–Causative organisms include
Escherichia coli and Pseudomonas,
Enterobacter, and Serratia species.
Residents of chronic care facilities
are at risk for gram-negative
pneumonia.
• Intrinsic factors : related to the host's immune
response, the presence of comorbidities, and
other risk factors:
– Loss of protective reflexes allows aspiration
of oropharyngeal flora into the lung.
• Aspiration is facilitated by altered mental
status from intoxication, deranged
metabolic states, neurological causes (eg,
stroke), and endotracheal intubation.
– Local lung pathologies (eg, tumors, chronic
obstructive pulmonary disease [COPD],
bronchiectasis).
– Smoking impairs the host's defense to
infection by a variety of mechanisms.
• Aspiration pneumonia is observed in
individuals with altered sensorium (eg,
seizures, alcohol intoxication, drug
intoxication) or CNS impairment (eg,
stroke).
– The stomach or oropharyngeal contents are
aspirated.
Complications of Pneumonia
• Destruction of lung tissue from infection
(leading to bronchiectasis)
• Organization of the exudate
• Abscess formation
• Spread of the infection to the pleural cavity
(empyema)
• Sepsis & Pyemia
• Respiratory failure
• Acute respiratory distress syndrome
• Superinfection with gram-negative organisms
• Death
1. Pneumonia
•1.1. Bronchopneumonia
•1.2. Lobar pneumonia
•1.3. Viral (Atypical)
pneumonia
Bronchopneumonia
Bronchopneumonia
1.2. Lobar Pneumonia
• Fibrinosuppurative consolidation – whole
lobe
• Rare (due to antibiotic treatment)
• ~95% - Strep. pneumoniae types 1,3,7& 2
• Four stages (Laennec,1838) :
– Congestion & edema (1 to 2 days)
– Red Hepatization (2-4 days )
– Gray Hepatization (4 to 8 days)
– Resolution (1 to 3 weeks).
• Congestion & Edema:
This stage is characterized histologically
by:
– vascular engorgement,
– intra-alveolar fluid,
– small numbers of neutrophils,
– often numerous bacteria.
– Grossly, the lung is heavy and
hyperemic.
• Red hepatization:
– Vascular congestion persists,
– Extravasation of red cells into alveolar
spaces,
– Increased numbers of neutrophils and
fibrin.
– The filling of airspaces by the exudate
leads to a gross appearance of
solidification, or consolidation, of the
alveolar parenchyma.
– A dry, granular, dark-red lung surface
on gross appearance
• This appearance has been likened to
that of the liver, hence the term
"hepatization".
• Gray hepatization:
–As pneumonia progresses over 2-3
days, erythrocytes are lysed with
persistence of the neutrophils and
fibrin and, epithelial cells degenerate
–The alveoli still appear consolidated,
but grossly the color is paler and the
cut surface is drier.
• Resolution:
– The exudate is digested by enzymatic
activity, and cleared by macrophages or
by cough mechanism.
– Dying pneumococci release a preformed
toxin, further contributing to this
damage.
– The pneumococci are opsonized by
leukocytes and begin to be cleared.
– Resolution results in the formation of
jellylike yellowish-colored exudates.
– Absorption of these exudates is
remarkably efficient, with little
organization or permanent scaring.
Lobar Pneumonia
Lobar Pneumonia – Gray hepatization

Contenu connexe

Tendances (20)

Interstitial lung disease
Interstitial lung diseaseInterstitial lung disease
Interstitial lung disease
 
Interstitial lung diseases
Interstitial lung diseases Interstitial lung diseases
Interstitial lung diseases
 
Lung abscess
Lung abscessLung abscess
Lung abscess
 
Interstitial Lung Diseases [ILD] Approach to Management
Interstitial Lung Diseases [ILD] Approach to ManagementInterstitial Lung Diseases [ILD] Approach to Management
Interstitial Lung Diseases [ILD] Approach to Management
 
Bronchiectasis
BronchiectasisBronchiectasis
Bronchiectasis
 
Bronchiectasis - causes and diagnosis
Bronchiectasis - causes and diagnosisBronchiectasis - causes and diagnosis
Bronchiectasis - causes and diagnosis
 
Bronchiectasis
Bronchiectasis Bronchiectasis
Bronchiectasis
 
Bronchiectasis
BronchiectasisBronchiectasis
Bronchiectasis
 
Bronchiectasis and pulmonary hypertension medical students
Bronchiectasis and pulmonary hypertension medical studentsBronchiectasis and pulmonary hypertension medical students
Bronchiectasis and pulmonary hypertension medical students
 
Pulmonary fibrosis
Pulmonary fibrosis   Pulmonary fibrosis
Pulmonary fibrosis
 
Ap 50 10-29 1 pathology of lung 1
Ap 50 10-29 1 pathology of lung 1Ap 50 10-29 1 pathology of lung 1
Ap 50 10-29 1 pathology of lung 1
 
Radiological features of pneumonia
Radiological features of pneumoniaRadiological features of pneumonia
Radiological features of pneumonia
 
4 bronchiectasis
4 bronchiectasis4 bronchiectasis
4 bronchiectasis
 
Bronchiectasis
BronchiectasisBronchiectasis
Bronchiectasis
 
Lung Abscess, Pulmonolgy
Lung Abscess, PulmonolgyLung Abscess, Pulmonolgy
Lung Abscess, Pulmonolgy
 
Interstitial lung fibrosis diseases
Interstitial lung fibrosis diseasesInterstitial lung fibrosis diseases
Interstitial lung fibrosis diseases
 
interstitial lung disease
interstitial lung diseaseinterstitial lung disease
interstitial lung disease
 
Lungabscess 171204080119
Lungabscess 171204080119Lungabscess 171204080119
Lungabscess 171204080119
 
Approach To Interstitial Lung Diseases
Approach To Interstitial Lung DiseasesApproach To Interstitial Lung Diseases
Approach To Interstitial Lung Diseases
 
LUNG ABSCESS
LUNG ABSCESSLUNG ABSCESS
LUNG ABSCESS
 

En vedette

Lung tumors 18 5-2016
Lung tumors 18 5-2016Lung tumors 18 5-2016
Lung tumors 18 5-2016pathologydept
 
Chromosomal disorders 27 10-2016
Chromosomal disorders  27 10-2016Chromosomal disorders  27 10-2016
Chromosomal disorders 27 10-2016pathologydept
 
Introduction to genetic disorders, classification 26 10-2016
Introduction to genetic disorders, classification 26 10-2016Introduction to genetic disorders, classification 26 10-2016
Introduction to genetic disorders, classification 26 10-2016pathologydept
 
Hyperemia and congestion edema
Hyperemia and congestion edema Hyperemia and congestion edema
Hyperemia and congestion edema pathologydept
 
Antipsychotics
AntipsychoticsAntipsychotics
AntipsychoticsDr. Pooja
 
Intracellular accumulations and calcifications 22 9-2016
Intracellular accumulations and calcifications 22 9-2016Intracellular accumulations and calcifications 22 9-2016
Intracellular accumulations and calcifications 22 9-2016pathologydept
 
Quick Clinical Review of Antipsychotics
Quick Clinical Review of AntipsychoticsQuick Clinical Review of Antipsychotics
Quick Clinical Review of AntipsychoticsShah Parind
 
Ventilator associated pneumonia
Ventilator associated pneumoniaVentilator associated pneumonia
Ventilator associated pneumoniaBeena Philip
 

En vedette (18)

Lung tumors 18 5-2016
Lung tumors 18 5-2016Lung tumors 18 5-2016
Lung tumors 18 5-2016
 
16.hypolipidemics
16.hypolipidemics16.hypolipidemics
16.hypolipidemics
 
Bone 2
Bone 2Bone 2
Bone 2
 
Anti psychotics
Anti psychoticsAnti psychotics
Anti psychotics
 
Chromosomal disorders 27 10-2016
Chromosomal disorders  27 10-2016Chromosomal disorders  27 10-2016
Chromosomal disorders 27 10-2016
 
Vaccines 1
Vaccines  1Vaccines  1
Vaccines 1
 
Introduction to genetic disorders, classification 26 10-2016
Introduction to genetic disorders, classification 26 10-2016Introduction to genetic disorders, classification 26 10-2016
Introduction to genetic disorders, classification 26 10-2016
 
Imaginary friends.
Imaginary friends.Imaginary friends.
Imaginary friends.
 
Hyperemia and congestion edema
Hyperemia and congestion edema Hyperemia and congestion edema
Hyperemia and congestion edema
 
Antipsychotics
AntipsychoticsAntipsychotics
Antipsychotics
 
Intracellular accumulations and calcifications 22 9-2016
Intracellular accumulations and calcifications 22 9-2016Intracellular accumulations and calcifications 22 9-2016
Intracellular accumulations and calcifications 22 9-2016
 
Quick Clinical Review of Antipsychotics
Quick Clinical Review of AntipsychoticsQuick Clinical Review of Antipsychotics
Quick Clinical Review of Antipsychotics
 
Lung pathology
Lung pathologyLung pathology
Lung pathology
 
Ventilator associated pneumonia
Ventilator associated pneumoniaVentilator associated pneumonia
Ventilator associated pneumonia
 
Pharmacology of absorption and bioavailability
Pharmacology of absorption and bioavailabilityPharmacology of absorption and bioavailability
Pharmacology of absorption and bioavailability
 
Hypolipidemic agents
Hypolipidemic agentsHypolipidemic agents
Hypolipidemic agents
 
Pharmacotherapy of Asthma
Pharmacotherapy of AsthmaPharmacotherapy of Asthma
Pharmacotherapy of Asthma
 
Routes of Administration Pharmacology
Routes of Administration PharmacologyRoutes of Administration Pharmacology
Routes of Administration Pharmacology
 

Similaire à Intrestitial lung disease 16 5-2016

pneumonia for C-1.pptx
pneumonia for C-1.pptxpneumonia for C-1.pptx
pneumonia for C-1.pptxIbsaAli1
 
Pathology basic introduction to pathology of common lung diseases for underg...
Pathology basic introduction to pathology of common lung diseases  for underg...Pathology basic introduction to pathology of common lung diseases  for underg...
Pathology basic introduction to pathology of common lung diseases for underg...Sufia Husain
 
Pulmonary inections.pptx
Pulmonary inections.pptxPulmonary inections.pptx
Pulmonary inections.pptxyusufArashid
 
Pulmonary_inections[1].pptx
Pulmonary_inections[1].pptxPulmonary_inections[1].pptx
Pulmonary_inections[1].pptxkhaalidmohamed6
 
Pathology of Acute Lungi Injury- Recent advances
Pathology of Acute Lungi Injury- Recent advancesPathology of Acute Lungi Injury- Recent advances
Pathology of Acute Lungi Injury- Recent advancesDr Snehal Kosale
 
2) chest soft tisue Radiological for helminth infections.pptx
2) chest soft tisue Radiological for helminth infections.pptx2) chest soft tisue Radiological for helminth infections.pptx
2) chest soft tisue Radiological for helminth infections.pptxIbrahimAboAlasaad
 
Interstitial lung disease final
Interstitial lung disease finalInterstitial lung disease final
Interstitial lung disease finalShivaom Chaurasia
 
Childhood pneumonia
Childhood pneumoniaChildhood pneumonia
Childhood pneumoniabirhanu abie
 
PNEUMONIA.pptx
PNEUMONIA.pptxPNEUMONIA.pptx
PNEUMONIA.pptxSAMOEINESH
 
Pulmonary Infections
Pulmonary InfectionsPulmonary Infections
Pulmonary InfectionsPrasad CSBR
 
Pulmonary Aspergillosis-1.pptx
Pulmonary Aspergillosis-1.pptxPulmonary Aspergillosis-1.pptx
Pulmonary Aspergillosis-1.pptxKemi Adaramola
 

Similaire à Intrestitial lung disease 16 5-2016 (20)

pneumonia for C-1.pptx
pneumonia for C-1.pptxpneumonia for C-1.pptx
pneumonia for C-1.pptx
 
Pathology basic introduction to pathology of common lung diseases for underg...
Pathology basic introduction to pathology of common lung diseases  for underg...Pathology basic introduction to pathology of common lung diseases  for underg...
Pathology basic introduction to pathology of common lung diseases for underg...
 
PNEUMONIA.pptx
PNEUMONIA.pptxPNEUMONIA.pptx
PNEUMONIA.pptx
 
Pneumonia
PneumoniaPneumonia
Pneumonia
 
PNEUMONIA.pptx
PNEUMONIA.pptxPNEUMONIA.pptx
PNEUMONIA.pptx
 
Pulmonary inections.pptx
Pulmonary inections.pptxPulmonary inections.pptx
Pulmonary inections.pptx
 
Pulmonary_inections[1].pptx
Pulmonary_inections[1].pptxPulmonary_inections[1].pptx
Pulmonary_inections[1].pptx
 
Pneumonia
PneumoniaPneumonia
Pneumonia
 
Pneumonia
PneumoniaPneumonia
Pneumonia
 
Pathology of Acute Lungi Injury- Recent advances
Pathology of Acute Lungi Injury- Recent advancesPathology of Acute Lungi Injury- Recent advances
Pathology of Acute Lungi Injury- Recent advances
 
2) chest soft tisue Radiological for helminth infections.pptx
2) chest soft tisue Radiological for helminth infections.pptx2) chest soft tisue Radiological for helminth infections.pptx
2) chest soft tisue Radiological for helminth infections.pptx
 
Interstitial lung disease final
Interstitial lung disease finalInterstitial lung disease final
Interstitial lung disease final
 
Interstitial lung disease
Interstitial lung diseaseInterstitial lung disease
Interstitial lung disease
 
Pneumonia
PneumoniaPneumonia
Pneumonia
 
pneumonia00.pdf
pneumonia00.pdfpneumonia00.pdf
pneumonia00.pdf
 
Gwen med surg pneumonia final
Gwen med surg pneumonia finalGwen med surg pneumonia final
Gwen med surg pneumonia final
 
Childhood pneumonia
Childhood pneumoniaChildhood pneumonia
Childhood pneumonia
 
PNEUMONIA.pptx
PNEUMONIA.pptxPNEUMONIA.pptx
PNEUMONIA.pptx
 
Pulmonary Infections
Pulmonary InfectionsPulmonary Infections
Pulmonary Infections
 
Pulmonary Aspergillosis-1.pptx
Pulmonary Aspergillosis-1.pptxPulmonary Aspergillosis-1.pptx
Pulmonary Aspergillosis-1.pptx
 

Plus de pathologydept

Embolism & infarction 14 10-2016
Embolism & infarction 14 10-2016Embolism & infarction 14 10-2016
Embolism & infarction 14 10-2016pathologydept
 
Thrombosis 13 10-2016
Thrombosis 13 10-2016Thrombosis 13 10-2016
Thrombosis 13 10-2016pathologydept
 
Non neoplastic bone diseases
Non neoplastic bone diseasesNon neoplastic bone diseases
Non neoplastic bone diseasespathologydept
 
Chronic inflammation
Chronic inflammationChronic inflammation
Chronic inflammationpathologydept
 
Acute inflammation handouts 30 9-2016
Acute inflammation handouts 30 9-2016Acute inflammation handouts 30 9-2016
Acute inflammation handouts 30 9-2016pathologydept
 
Chronic inflammation 5 10-2016
Chronic inflammation 5 10-2016Chronic inflammation 5 10-2016
Chronic inflammation 5 10-2016pathologydept
 
Body immune response
Body immune responseBody immune response
Body immune responsepathologydept
 
Cell injury handouts 14 9-2016
Cell injury handouts 14 9-2016Cell injury handouts 14 9-2016
Cell injury handouts 14 9-2016pathologydept
 
Non neoplastic lesions of breast dr. mangala 14-9-2016
Non neoplastic lesions of breast dr. mangala 14-9-2016Non neoplastic lesions of breast dr. mangala 14-9-2016
Non neoplastic lesions of breast dr. mangala 14-9-2016pathologydept
 
Salivary gland tumors 23 5-2016
Salivary gland tumors 23 5-2016Salivary gland tumors 23 5-2016
Salivary gland tumors 23 5-2016pathologydept
 
Cardiomyopathy,myocarditis,pericarditi,tumor
Cardiomyopathy,myocarditis,pericarditi,tumorCardiomyopathy,myocarditis,pericarditi,tumor
Cardiomyopathy,myocarditis,pericarditi,tumorpathologydept
 
Congenital cardiac ...... lecture 61 18 4-2016
Congenital cardiac ...... lecture 61 18 4-2016Congenital cardiac ...... lecture 61 18 4-2016
Congenital cardiac ...... lecture 61 18 4-2016pathologydept
 
Infective endocarditis 16 4-2016
Infective endocarditis 16 4-2016Infective endocarditis 16 4-2016
Infective endocarditis 16 4-2016pathologydept
 
4 4-2016 myocardial infarction
4 4-2016 myocardial infarction4 4-2016 myocardial infarction
4 4-2016 myocardial infarctionpathologydept
 
Non neoplastic ln revised
Non neoplastic ln revisedNon neoplastic ln revised
Non neoplastic ln revisedpathologydept
 
Chronicmyeloproliferative neoplasm ,cll
Chronicmyeloproliferative neoplasm ,cllChronicmyeloproliferative neoplasm ,cll
Chronicmyeloproliferative neoplasm ,cllpathologydept
 

Plus de pathologydept (19)

Embolism & infarction 14 10-2016
Embolism & infarction 14 10-2016Embolism & infarction 14 10-2016
Embolism & infarction 14 10-2016
 
Thrombosis 13 10-2016
Thrombosis 13 10-2016Thrombosis 13 10-2016
Thrombosis 13 10-2016
 
Non neoplastic bone diseases
Non neoplastic bone diseasesNon neoplastic bone diseases
Non neoplastic bone diseases
 
Wound healing
Wound healingWound healing
Wound healing
 
Chronic inflammation
Chronic inflammationChronic inflammation
Chronic inflammation
 
Acute inflammation handouts 30 9-2016
Acute inflammation handouts 30 9-2016Acute inflammation handouts 30 9-2016
Acute inflammation handouts 30 9-2016
 
Chronic inflammation 5 10-2016
Chronic inflammation 5 10-2016Chronic inflammation 5 10-2016
Chronic inflammation 5 10-2016
 
Body immune response
Body immune responseBody immune response
Body immune response
 
Cell injury handouts 14 9-2016
Cell injury handouts 14 9-2016Cell injury handouts 14 9-2016
Cell injury handouts 14 9-2016
 
Non neoplastic lesions of breast dr. mangala 14-9-2016
Non neoplastic lesions of breast dr. mangala 14-9-2016Non neoplastic lesions of breast dr. mangala 14-9-2016
Non neoplastic lesions of breast dr. mangala 14-9-2016
 
Salivary gland tumors 23 5-2016
Salivary gland tumors 23 5-2016Salivary gland tumors 23 5-2016
Salivary gland tumors 23 5-2016
 
Copd 2 5-2016 madhu
Copd 2 5-2016 madhuCopd 2 5-2016 madhu
Copd 2 5-2016 madhu
 
Cardiomyopathy,myocarditis,pericarditi,tumor
Cardiomyopathy,myocarditis,pericarditi,tumorCardiomyopathy,myocarditis,pericarditi,tumor
Cardiomyopathy,myocarditis,pericarditi,tumor
 
Congenital cardiac ...... lecture 61 18 4-2016
Congenital cardiac ...... lecture 61 18 4-2016Congenital cardiac ...... lecture 61 18 4-2016
Congenital cardiac ...... lecture 61 18 4-2016
 
Infective endocarditis 16 4-2016
Infective endocarditis 16 4-2016Infective endocarditis 16 4-2016
Infective endocarditis 16 4-2016
 
Rhd 11 4-2016
Rhd 11 4-2016Rhd 11 4-2016
Rhd 11 4-2016
 
4 4-2016 myocardial infarction
4 4-2016 myocardial infarction4 4-2016 myocardial infarction
4 4-2016 myocardial infarction
 
Non neoplastic ln revised
Non neoplastic ln revisedNon neoplastic ln revised
Non neoplastic ln revised
 
Chronicmyeloproliferative neoplasm ,cll
Chronicmyeloproliferative neoplasm ,cllChronicmyeloproliferative neoplasm ,cll
Chronicmyeloproliferative neoplasm ,cll
 

Dernier

ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMADivya Kanojiya
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseSreenivasa Reddy Thalla
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfHongBiThi1
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxDr.Nusrat Tariq
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt downloadAnkitKumar311566
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAAjennyeacort
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxEyobAlemu11
 
low cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxlow cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxdrashraf369
 

Dernier (20)

ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies Disease
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptx
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt download
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptx
 
low cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxlow cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptx
 

Intrestitial lung disease 16 5-2016

  • 1. Interstitial Lung Disease & Pulmonary Infection Dr. Vinita Singh
  • 2. CASE-1 A routine chest X- ray performed on an asymptomatic adult man who works at sandblasting reveals a fine nodularity in the upper zone of the lung and “eggshell” calcification of the hilar lymph nodes. The Pt. S.calcium level is 9.8m/dl total protein is7.2g/dl. He denies any H/O drug use or ciggarette smoking.
  • 3. Cond, A biopsy from lung reveal birefringent particles within macrophages and fibrosis of lung. what is the material ?
  • 4. CASE -2 A 65yr old man who just retired after having worked for many years as a shipyard worker presents with increasing shortness of breath. Pertinent medical history is that he has been a long time smoker. A CT Scan of his chest reveals thick , pleural Plaques on the surface of his lungs.
  • 5. Cond, The Dumbbell – Shaped structures were found to stain blue with a prussian blue stain . What are these structures ?
  • 6. IMPORTANT CAUSES OF ILD 1. Primary or idiopathic • Idiopathic Pulmonary Fibrosis • Nonspecific interstitial pneumonia (NSIP) • Organising pneumonia (OP) • Respiratory bronchiolitis (RB) • Diffuse alveolar damage (DAD) • Desquamative interstitial pneumonia (DIP) • Lymphocytic interstitial pneumonia (LIP)
  • 7. Secondary Causes 1.Infectious • Tuberculosis • Bacterial • Fungal • Parasitic • Viral 2. Noninfectious • Hypersensitivity pneumonitis • Pneumoconiosis • Drug induced • Radiation induced • Malignancies
  • 8. Association with diseases of unknown aetiology • Sarcoidosis • Connective tissue disorders • Systemic sclerosis • Rheumatoid arthritis • Dermatomyositis,Polymyositis • SLE • Chronic eosinophilic pneumonia
  • 9. ILD is a heterogeneous syndrome with the following common clinical features: 1. Exertional dyspnea 2. Bilateral diffuse infiltrates on chest radiographs 3. Physiological abnormalities with a restrictive lung defect, decreased diffusing capacity (DLco) and abnormal alveolar- arterial oxygen gradient (PAO2 – PaO2) at rest or with exertion. 4. Absence of pulmonary infection and neoplasm. 5. Histopathology with varing degrees of fibrosis and inflammation with or without evidence of granulomatous or secondary vascular changes in the pulmonary parenchyma.
  • 10. Diffuse Parenchymal Lung Disease (DPLD) DPLD of known cause, eg, drugs or association, eg, collagen vascular disease Idiopathic interstitial pneumonias Granulomatous DPLD, eg, sarcoidosis Other forms of DPLD, eg, LAM, HX, etc Idiopathic pulmonary fibrosis IIP other than idiopathic pulmonary fibrosis Desquamative interstitial pneumonia Acute interstitial pneumonia Nonspecific interstitial pneumonia (provisional) Respiratory bronchiolitis interstitial lung disease Cryptogenic organizing pneumonia Lymphocytic interstitial pneumonia ATS/ERS Consensus Statement. Am J Respir Crit Care Med. 2002;165:277-304.
  • 11. PATHOLOGY • Pulmonary interstitium is the anatomical space between the alveolar and the capillary basement membranes. • Contains mesenchymal and connective tissue cells and extra cellular matrix composed of collagen, elastin and proteoglycans. • Involvement of interstitium+ adjoining alveolar epithelial+ Capillary endothelial cells. • Disease encroaches alveolar spaces involving acini, terminal bronchioles and overlying pleura.
  • 12. Inhaled environmental agents (fumes, dust, smoke) Alveolar epithelial cell injury Wound healing (inflammation, coagulation, epithelial/endothelial repair) Pulmonary fibrosis Normal Chronic airflow obstruction Genetic predisposition Delivery & persistence Biochemical Immunologic Fibrotic Four proposed mechanisms and potential variations in lung responses to inhaled agents
  • 13. Recent Hypothesis: • Inflammatory hypothesis • Epithelial Cell Apoptosis • Angiogenesis • Abnormal Matrix Turnover • Th1 versus Th2 Cytokines • Growth Factor Production • Altered Fibroblast Phenotypes • Myofibroblast Recruitment and Maintenance
  • 14. Thannickal VJ, et al. Annu Rev Med. 2004;55:395-417. AGE GENETIC FACTORS ENVIRONMENTAL FACTORS NATURE OF INJURY – Etiologic agent – Recurrent vs single – Endothelial vs epithelial Histopathologic Pattern DIP RB-ILD LIP COP NSIP AIP UIP Inflammation Fibrosis LUNG INJURY
  • 15. PATTERNS ON CHEST X-RAY LINEAR
  • 19. Normal Lung- cut surface and pleura smooth and homogenous IPF- cut surface demonstrates patchy involvement of lung with fibrous scarring around dilated airspaces forming a honey comb pattern IPF
  • 20. CASE-3 A 24yr old African American woman presents with nonspecific symptoms including fever malaise. A chest X –ray reveals enlarged hilar lymph nodes ( potato nodes) . serum calcium level is found to be elevated What is the probable diagnosis ?
  • 21. CASE -4 A 61yr old man presents with increasing shortness of breath . A chest X- ray reveals diff. Pulmonary infiltrate. transbronchial biopsy reveals fibrosis of the walls of the alveoli, many of which contain sheets of “ desquamated’’ cells. What is the probable diagnosis ?
  • 22. CASE -5 A 37yr old woman presents with acute onset of a productive cough, fever, chills and pleuritic chest pain. A chest X –ray reveals consolidation of the entire lower lobe of her right lung . Histologic examination of lung tissue reveals multiple suppurative , neutrophil – rich exudates filing bronchi , bronchioles and alveolar spaces.
  • 23. Cont’ 1. What is the probable diagnosis? 2. What is the etio – pathogenesis ?
  • 24. Etiology • Decreased resistance - General/immune • Virulent infection - Lobar pneumonia • Defense Mechanisms In the normal respiratory system there are a number of important defense mechanisms that protect the lung from infection. These include: – Reflex closure of the vocal cords – Cough reflex – Mucociliary clearance – Macrophage activity and immune competence.
  • 25. • An increased risk of bacterial infection is associated with impairment of the defense mechanism, as in any of these clinical situations: – Loss of consciousness – Immunodeficiency state – Pulmonary edema – Neutropenia – Chronic airway obstruction – Viral infection.
  • 26. • Exudate The exudate in bacterial pneumonia is typically composed of varying proportions of: – edema fluid – red blood cells – leukocytes (principally neutrophils) – fibrin • The cellular exudate in acute bacterial pneumonia is in the alveolar spaces and distal bronchioles though in severe cases the major airways may also be filled with purulent secretion.
  • 27. Types • Viral • Bacterial • Mycoplasmal • Fungal
  • 28. The Pneumonia Syndromes • Community-acquired acute pneumonia – Streptococcus pneumonia – Haemophilus influenza – Moraxella catarrhalis – Staphylococcus aureus – Legionella pneumophilia – Klebsiella – Pseudomonas • Community-acquired atypical pneumonia – Mycoplasma – Chlamydia – Legionella – Viruses (RSV, parainfluenza & influenza, adenovirus) • Nosocomial pneumonia – Gram negative rods – Staphlyococcus aureus • Aspiration pneumonia – Anaerobic oral flora – Amniotic fluid – Gastric content – Chemicals • Chronic pneumonia – Nocardia – Actinomyces – Granulomatous • Necrotizing pneumonia – Anaerobic – Staphlyococcus aureus – Klebsiella – Streptococcus pyogens
  • 29. Several possible routes of infection of the lung exist: – Aspiration of contaminated secretions-- most common – Inhalation of infected airborne droplets – Bacteremia – Direct extension of an acute inflammatory process from an adjacent organ or structure. Routes of Infection
  • 30. Etiopathogenesis • Causes of bacterial pneumonia can be categorized as extrinsic and intrinsic. • Extrinsic factors : infection with respiratory pathogens. Exposure to pulmonary irritants or direct pulmonary injury causes noninfectious pneumonitis. – Infectious agents responsible for bacterial pneumonias include S. pneumoniae and H. influenzae; Klebsiella, Staphylococcus, and Legionella species; and gram-negative organisms. – Aspiration and inhalation of aerosols containing the bacterial pathogen are the most common modes of infection. – Some bacteria, such as Staphylococcus species, may spread to the lungs hematogenously.
  • 31. • S. pneumoniae is the most common cause of bacterial pneumonia. • Pneumonia from H influenzae often is associated with debilitating conditions such as asthma, COPD, smoking, and a compromised immune system. • K. pneumoniae may cause a severe necrotizing lobar pneumonia in patients with chronic alcoholism, diabetes, or COPD. • S. aureus pneumonia is observed in those who abuse intravenous drugs. – S. aureus generally occurs in hospitalized patients and patients with prosthetic devices; it spreads hematogenously to the lungs from contaminated local sites. This pathogen also is an important cause of pneumonia following infection with influenza A. • L. pneumophila infections occur either sporadically or as local outbreaks.
  • 32. • Gram-negative pneumonias are observed in individuals who are immunocompromised or hospitalized. –Causative organisms include Escherichia coli and Pseudomonas, Enterobacter, and Serratia species. Residents of chronic care facilities are at risk for gram-negative pneumonia.
  • 33. • Intrinsic factors : related to the host's immune response, the presence of comorbidities, and other risk factors: – Loss of protective reflexes allows aspiration of oropharyngeal flora into the lung. • Aspiration is facilitated by altered mental status from intoxication, deranged metabolic states, neurological causes (eg, stroke), and endotracheal intubation. – Local lung pathologies (eg, tumors, chronic obstructive pulmonary disease [COPD], bronchiectasis). – Smoking impairs the host's defense to infection by a variety of mechanisms.
  • 34. • Aspiration pneumonia is observed in individuals with altered sensorium (eg, seizures, alcohol intoxication, drug intoxication) or CNS impairment (eg, stroke). – The stomach or oropharyngeal contents are aspirated.
  • 35. Complications of Pneumonia • Destruction of lung tissue from infection (leading to bronchiectasis) • Organization of the exudate • Abscess formation • Spread of the infection to the pleural cavity (empyema) • Sepsis & Pyemia • Respiratory failure • Acute respiratory distress syndrome • Superinfection with gram-negative organisms • Death
  • 36. 1. Pneumonia •1.1. Bronchopneumonia •1.2. Lobar pneumonia •1.3. Viral (Atypical) pneumonia
  • 39. 1.2. Lobar Pneumonia • Fibrinosuppurative consolidation – whole lobe • Rare (due to antibiotic treatment) • ~95% - Strep. pneumoniae types 1,3,7& 2 • Four stages (Laennec,1838) : – Congestion & edema (1 to 2 days) – Red Hepatization (2-4 days ) – Gray Hepatization (4 to 8 days) – Resolution (1 to 3 weeks).
  • 40. • Congestion & Edema: This stage is characterized histologically by: – vascular engorgement, – intra-alveolar fluid, – small numbers of neutrophils, – often numerous bacteria. – Grossly, the lung is heavy and hyperemic.
  • 41. • Red hepatization: – Vascular congestion persists, – Extravasation of red cells into alveolar spaces, – Increased numbers of neutrophils and fibrin. – The filling of airspaces by the exudate leads to a gross appearance of solidification, or consolidation, of the alveolar parenchyma. – A dry, granular, dark-red lung surface on gross appearance • This appearance has been likened to that of the liver, hence the term "hepatization".
  • 42. • Gray hepatization: –As pneumonia progresses over 2-3 days, erythrocytes are lysed with persistence of the neutrophils and fibrin and, epithelial cells degenerate –The alveoli still appear consolidated, but grossly the color is paler and the cut surface is drier.
  • 43. • Resolution: – The exudate is digested by enzymatic activity, and cleared by macrophages or by cough mechanism. – Dying pneumococci release a preformed toxin, further contributing to this damage. – The pneumococci are opsonized by leukocytes and begin to be cleared. – Resolution results in the formation of jellylike yellowish-colored exudates. – Absorption of these exudates is remarkably efficient, with little organization or permanent scaring.
  • 45. Lobar Pneumonia – Gray hepatization